glp 1 agonist cardiovascular outcomes Results of trials comparing GLP-1 receptor Cardiovascular outcomes trials for GLP-1

Special populations Patients with renal insufficiency Patients with severely impaired renal function should not be treated with chronic oral administration of high doses of levocarnitine because it may induce an accumulation of the potentially toxic metabolites trimethylamine (TMA) and trimethylamine-N-oxide (TMAO)

Glutathione is a tripeptide composed of three essential amino acids: Glutamine Cysteine Glycine This powerful antioxidant is naturally synthesized in the liver and plays a vital role in neutralizing free radicals, supporting cellular repair, and assisting in detoxification processes

Maksudov, F

DOI Dou Y, Lee A, Zhu L, et al